Eric Venker
Chief Executive Officer at Immunovant Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 1 year.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Roivant Sciences Ltd. | Open-market sale | −200,000 | $36.31 | $7,262,000 |
| Oct 28, 2026 | Roivant Sciences Ltd. | Open-market sale | −200,000 | $36.59 | $7,318,000 |
| Oct 20, 2026 | Roivant Sciences Ltd. | Open-market sale | −185,856 | $35.09 | $6,521,687 |
| Oct 20, 2026 | Roivant Sciences Ltd. | Open-market sale | −14,144 | $35.42 | $500,980 |
| Oct 2, 2026 | Immunovant Inc. | Open-market sale | −3,506 | $34.11 | $119,590 |
| Oct 1, 2026 | Immunovant Inc. | Option exercise | +92,187 | $14.46 | $1,333,024 |
| Oct 1, 2026 | Immunovant Inc. | Sold back to the company | −85,886 | $33.65 | $2,890,064 |
| Sep 30, 2026 | Roivant Sciences Ltd. | Option exercise | +200,000 | $3.85 | $770,000 |
| Sep 30, 2026 | Roivant Sciences Ltd. | Open-market sale | −200,000 | $36.62 | $7,324,000 |
| Aug 28, 2026 | Roivant Sciences Ltd. | Option exercise | +200,000 | $3.85 | $770,000 |
| Aug 28, 2026 | Roivant Sciences Ltd. | Open-market sale | −166,182 | $35.63 | $5,921,065 |
| Aug 28, 2026 | Roivant Sciences Ltd. | Open-market sale | −33,818 | $36.44 | $1,232,328 |
| Aug 20, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | −13,909 | $36.84 | $512,408 |
| Jul 27, 2026 | Roivant Sciences Ltd. | Option exercise | +200,000 | $3.85 | $770,000 |
| Jul 27, 2026 | Roivant Sciences Ltd. | Open-market sale | −200,000 | $34.95 | $6,990,000 |
Questions about Eric Venker
What boards is Eric Venker on?
Eric Venker sits on the board of Immunovant Inc.
What company is Eric Venker the CEO of?
Eric Venker is Chief Executive Officer of Immunovant Inc.
How long has Eric Venker served on boards?
Our records show at least 1 year of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.